DENOVX, LLC

Streamwood, IL · Medtech · Still private

Continuous flow crystallization modules with enhanced nucleation surfaces for pharmaceutical manufacturing

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · denovx.com

Sector: Medtech
Headquarters: Streamwood, IL
Total capital: $12.1M

Federal grants: $12.1M; 16 awards · 2015–2024; Rank in peer group#31 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 2 pending · first 2015; Rank in peer group#237 of 538

Capital timeline

Latest events

Sep 2024Federal grantHealth and Human S · Phase I · Improving Cryo-EM Specimen Quality Using Surface Science$350K
Aug 2023Federal grantHealth and Human S · Phase II · Advanced Nucleation Technologies for Membrane Protein Crystallization to Accelerate Structure-Based Drug Design for Substance Use Disorders$711K
Sep 2022Federal grantHealth and Human S · Phase II · Advanced Nucleation Technologies for Membrane Protein Crystallization to Accelerate Structure-Based Drug Design for Substance Use Disorders$1.8M
Jul 2021Federal grantHealth and Human S · Phase II · Multiplexed Nucleation Approaches for Enhanced High Throughput Screening of Co-Crystals$912K
Jul 2021Federal grantHealth and Human S · Phase I · Microfluidic Protein Flow Crystallization Using Engineered Nucleation Features for Serial and Traditional Crystallography$313K
Jul 2020Federal grantHealth and Human S · Phase II · Multiplexed Nucleation Approaches for Enhanced High Throughput Screening of Co-Crystals$1.1M
Mar 2020Federal grantHealth and Human S · Phase II · Nucleation Enhanced Crystallization of Pharmaceuticals in Continuous Flow Manufacturing to Mitigate Therapeutic Drug Shortages$669K

Show 9 earlier federal awards

Mar 2019Federal grantHealth and Human S · Phase II · Nucleation Enhanced Crystallization of Pharmaceuticals in Continuous Flow Manufacturing to Mitigate Therapeutic Drug Shortages$1.5M
Aug 2018Federal grantHealth and Human S · Phase II · Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins-Administrative Supplement-Instrumentation-Dynamic Light Scattering of Protein Aggregates$87K
Aug 2018Federal grantHealth and Human S · Phase II · Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins$861K
Jul 2018Federal grantHealth and Human S · Phase I · Advanced Nucleation Technologies for Membrane Protein Crystallization to Accelerate Structure-Based Drug Design for Substance Use Disorders$350K
Sep 2017Federal grantHealth and Human S · Phase II · Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins-Administrative Supplement-Instrumentation-Dynamic Light Scattering of Protein Aggregates$1.9M
Aug 2017Federal grantHealth and Human S · Phase II · Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins$931K
Apr 2016Federal grantHealth and Human S · Phase I · Multiplexed Nucleation Approaches for Enhanced High Throughput Screening of Co-Crystals$312K
Mar 2016Federal grantHealth and Human S · Phase I · Nucleation Enhanced Crystallization of Pharmaceuticals in Continuous Flow Manufacturing to Mitigate Therapeutic Drug Shortages$225K
Jan 2015Federal grantHealth and Human S · Phase I · Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins$224K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#31 · top 6%
Granted patents#237 · top 44%
Linked publications#22 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 3

Nov 24, 2015GrantedDirected Nucleation And Crystal Growth From Solution Using Surface Energy Modified Amorphous MaterialsUSPTOUS 9,193,664
PendingDirected Nucleation And Crystal Growth From Solution Using Surface Energy Modified Amorphous MaterialsUSPTOApplication PCTUS2014025089
PendingDirected Nucleation And Crystal Growth From Solution Using Surface Energy Modified Amorphous MaterialsUSPTOApplication 61794821

Recent research by its founders

GECTurk: Grammatical Error Correction and Detection Dataset for Turkish20233 cites
GECTurk: Grammatical Error Correction and Detection Dataset for Turkish20230 cites
Bismuth coordination chemistry: a brief retrospective spanning crystallography to clinical potential20215 cites

Elekta ABSimilar federal contract value in Medtech · null in contracts
ReValve Med, Inc.Similar federal contract value in Medtech · null in contracts
SPOT ON SCIENCES, LLCSimilar federal contract value in Medtech · null in contracts
Hydro-Gen LLCSimilar federal contract value in Medtech · null in contracts
Pneuma Respiratory, Inc.Similar federal contract value in Medtech · null in contracts
RALPHVR INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.